CD274 and hepatocellular carcinoma: Previous studies have reported that TMB values, TIDE scores, expression of immune checkpoint molecules (e.g., PD-L1 and PD-1), and the degree of immune cell infiltration can predict the response of patients with HCC to immunotherapy [71–73].